Global Erectile Dysfunction Drugs Market 2018, Comprehensive Analysis, Industry Survey, Growth and Major Policies Report

Our latest research report entitled Erectile Dysfunction Drugs Market (by drug (sildenafil (viagra), tadalafil (cialis), vardenafil (levitra, staxyn), avanafil (stendra), muse suppository (alprostadil)), mode of administration (oral, topical, injections), end-user (hospital pharmacies, retail pharmacies, and online pharmacies)) provides complete and deep insights into the market dynamics and growth of erectile dysfunction drugs. The latest information on market risks, industry chain structure erectile dysfunction drugs cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential erectile dysfunction drugs growth factors. According to the report, the global erectile dysfunction drugs market is projected to grow at a CAGR of 6.8% over the forecast period of 2018-2024.

We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

Erectile dysfunction is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. It is caused due to several physical and psychological issues such as stress, hypertension, heart disease, obesity and surgeries or injuries that affect the pelvic area or spinal cord. These drugs work by relaxing smooth muscle cells to improve the flow of blood into the penis by making the erections easier to get and maintain. They are a safe and effective way to cure erectile dysfunction. The most commonly used erectile dysfunction drugs are Viagra, Stendra, Cialis and Levitra.

Rise in Aging Population Contributes to the Growth of Erectile Dysfunction Drugs Market

The rise in aging population contributes to the growth of erectile dysfunction drugs market. Epidemiological studies consistently show that the prevalence of erectile dysfunction increases with aging. Erectile dysfunction affects as many as 20 million American men. Nonetheless, younger men are also suffering from erectile dysfunction owing to lifestyle choices such as smoking, overuse of alcohol, poor diet, and lack of physical activity. In addition, the increase in the number of men suffering from metabolic and cardiovascular diseases drives the growth of the erectile dysfunctional drug market. Nearly 133 million Americans suffer from at least one chronic disease, and the number is growing. Other organic causes of impotence in men include neurological problems, hormonal insufficiencies, and drug side effects.

However, erectile dysfunction drugs can be dangerous when combined with other medications. Erectile dysfunction drugs cause side effects such as headache, muscle aches, heartburn, diarrhea, visual changes, hearing loss, nasal congestion, and long-lasting erection in men curtails the growth of erectile dysfunction drugs market. Furthermore, increasing awareness about cures for erectile dysfunction and the emergence of generic drugs and new drug delivery techniques will create additional growth opportunities for the growth of the erectile dysfunction drug market. Moreover, the expiry of patents of several erectile dysfunction drugs is also projected to drive the growth of this market over the forecast period.

Get this Section as a Free Customization in the Report along with 30% Discount on the Study:

“We have Decided to Extend our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Global on Erectile Dysfunction Drugs Market Amidst COVID-19.”

North America Holds the Maximum Market Share in the Erectile Dysfunction Drug Market

Among the geographies, North America holds the maximum market share in the erectile dysfunction drug market. The rising prevalence of erectile dysfunction among men in the North America region owing to the sedentary lifestyle and growing awareness the treatment methods for curing erectile dysfunction drives the growth of erectile dysfunction drug market in this region. Europe is the second-largest region owing to the increasing incidences of cardiac diseases in this region. Asia-Pacific is the fastest-growing in the erectile dysfunction drug market. The rise in the aging population in the Asia Pacific region drives the growth of erectile dysfunction drug market in this region.

Erectile Dysfunction Drugs Market: Segmentation

The report on global erectile dysfunction drugs market covers segments such as a drug, mode of administration, and end-user. On the basis of a drug, the sub-markets include sildenafil (viagra), tadalafil (cialis), vardenafil (levitra,staxyn), avanafil (stendra), muse suppository (alprostadil), and others. On the basis of mode of administration, the sub-markets include oral, topical, injections, and others. On the basis of end-user, the sub-markets include hospital pharmacies, retail pharmacies, and online pharmacies.

Key Players in the Erectile Dysfunction Drugs Industry

The report provides profiles of the companies in the market such as Pfizer Inc., Bayer AG, Eli Lily & Co., DONG–A PHARM, Apricus Biosciences Inc., Vivus, Inc., Meda AB, SK Chemicals, CristaliaProdutosQuimicosFarmaceuticos Ltda., and Teva Pharmaceutical Industries Ltd.

Browse Detailed TOC, Description, and Companies Mentioned in Report @

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the erectile dysfunction drugs.
  • Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2024.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis, and the latest developments of the company.
  • Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.